REPLACE DARE (death after replacement evaluation) score: Determinants of all-cause mortality after implantable device replacement or upgrade from the replace registry

Replace Investigators

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Background: Identifying factors predictive of mortality may be important to decrease risk associated with cardiac implantable electrical device (CIED) replacement procedures. This study aimed to determine whether clinical factors and complications independently associate with death and to develop a mortality risk prediction tool after CIED replacement. Methods and Results: The prospective REPLACE Registry determined 6-month complication and mortality rates after CIED replacement with or without planned lead addition or revision. Vital status was collected. Kaplan-Meier survival and multivariable Cox proportional hazards regression analyses were performed to identify patient, procedural, or complication variables predictive of death. The REPLACE DARE (Death After Replacement Evaluation) Score was constructed using hazard ratios, reflecting relative risk contributions of each variable, combined into an additive mortality risk score equation. At 6 months, 70 of 1744 (4.0%) patients had died. Cox regression analysis found no significant association between major complications and death. However, recent heart failure admission, New York Heart Association class III/IV, antiarrhythmic drug use, cerebrovascular disease, and chronic kidney disease stage were independently associated with 6-month mortality. The REPLACE DARE Score was 2.0±1.4 in survivors versus 3.5±1.8 in nonsurvivors (P<0.001), with predictive receiver operating characteristic value=0.758 (P<0.001). Risk of death was 1.0% for DARE=0 and 55.6% for DARE=7. The hazard ratio was 1.8 for each change of 1 DARE unit. Conclusions: Comorbidities, but not complications, were significantly associated with mortality after CIED replacement. The REPLACE DARE Score is a novel tool that can identify patients with substantial mortality risk. Such patients should have the relative risk and benefit of their procedure considered carefully.

Original languageEnglish
Pages (from-to)1048-1056
Number of pages9
JournalCirculation: Arrhythmia and Electrophysiology
Volume7
Issue number6
DOIs
StatePublished - Dec 1 2014
Externally publishedYes

Keywords

  • Defibrillators, implantable
  • Mortality
  • Pacemakers

Fingerprint Dive into the research topics of 'REPLACE DARE (death after replacement evaluation) score: Determinants of all-cause mortality after implantable device replacement or upgrade from the replace registry'. Together they form a unique fingerprint.

Cite this